Written by Taylor B.
Published October 11, 2025

A black box warning is the FDA's strongest prescription-label warning. It means there's a serious or life-threatening risk worth highlighting — not that the medication shouldn't be used, but that providers and patients should be aware of specific precautions.
The branded GLP-1 medications (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) carry a black box warning regarding thyroid C-cell tumors, based on rodent studies. These medications are contraindicated for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Share this article

Complete your free online visit and see if GLP-1 treatment is right for you.
Get Started